top of page
  • White Facebook Icon
  • White Twitter Icon

ADRB3

Name of Protein

Beta-3 adrenergic receptor

Protein Function

Year Discovered

Regulates lipolysis and energy expenditure

1989
ADRB3

Y

The beta-3 adrenergic receptor (β3-AR) is a cell surface G-protein coupled receptor (GPCR) that plays a crucial role in regulating energy homeostasis, lipid metabolism, and thermogenesis. It is one of the three known beta-adrenergic receptor subtypes (β1-AR, β2-AR, and β3-AR), which mediate the effects of catecholamines, such as adrenaline and noradrenaline, on various physiological processes.

β3-AR is predominantly expressed in adipose tissue, particularly in brown and white adipocytes, as well as in the urinary bladder and the gastrointestinal tract. In adipose tissue, activation of β3-AR by its ligands leads to the stimulation of adenylate cyclase, which in turn increases intracellular cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which then phosphorylates various downstream targets, ultimately promoting lipolysis and thermogenesis.

In brown adipose tissue (BAT), β3-AR activation enhances the breakdown of triglycerides into free fatty acids, which are subsequently oxidized to generate heat through a process known as non-shivering thermogenesis. This process is mediated by the mitochondrial uncoupling protein 1 (UCP1), which dissipates the proton gradient across the inner mitochondrial membrane, converting chemical energy into heat. In white adipose tissue (WAT), β3-AR activation stimulates lipolysis and may promote the "browning" of white adipocytes, increasing their thermogenic capacity.

The β3-AR has been identified as a potential therapeutic target for obesity and related metabolic disorders. Pharmacological activation of β3-AR has been shown to increase energy expenditure, reduce adiposity, and improve insulin sensitivity in animal models. However, the development of selective β3-AR agonists for human use has been challenging due to species differences in receptor pharmacology and function. Further research is needed to fully understand the therapeutic potential of targeting β3-AR in the treatment of obesity and metabolic diseases.

In summary, the beta-3 adrenergic receptor (β3-AR) is a GPCR involved in the regulation of energy homeostasis, lipid metabolism, and thermogenesis, primarily through its expression in adipose tissue. Activation of β3-AR promotes lipolysis and thermogenesis, making it an attractive target for the development of novel therapeutics aimed at treating obesity and related metabolic disorders.

HOLLAND CLINIC uses AI to Supercharge Your Care

See how we are using artificial intelligence (AI) to bring your care to a whole new level

Logo for Holland Clinic's new AI powered weight loss program

This website is intended to provide information about medical weight loss. However, no information presented here should be construed as medical advice. This website is for informational and educational purposes only. Before starting any weight loss program, it is important to consult with your health care provider to ensure the program is safe and appropriate for you. Your health care provider can provide personalized guidance, advice, and support to help you reach your weight loss goals. If you choose Dr. Holland as your provider, you should only follow the advice he gives you personally during your meetings with him and if you are uncertain about your care you should contact Holland Clinic and not rely on this website.

© 2024 by Holland Clinic, Inc.  All rights reserved

Holland Clinic
Medical Weight Loss Program
Mark J. Holland MD
2440 Louisiana NE, Suite 540
Albuquerque, New Mexico  87110
(505) 232-6818
bottom of page